Home' Australian Pharmacist : Australian Pharmacist January 2013 Contents Australian Pharmacist January 2013 I ©Pharmaceutical Society of Australia Ltd. 19
recognising and allowing for payment of
the essential clinical pharmacy services
which have historically been cross
subsidised through the reimbursed price
of medicines and associated dispensing.
SHPA supports efficient pricing of all
medicines and ensuring that tax payers'
money is not wasted, and recognises
the need for a sustainable private health
system to complement the public
health system. However, the current
remuneration model for chemotherapy
does not reflect how contemporary
cancer services are delivered.
SHPA supports a sustainable, transparent
and fair funding model for the provision
of chemotherapy medicines that:
• supports equity of access across the
country and is equally applicable
across all hospitals / types of pharmacy
services and whether or not an external
compounder is used;
• covers in full the cost of the medicine
• provides reimbursement for the
range of costs associated with the
reconstitution and preparation
of the medicine or medicines in a
ready-to-use form; and
• recognises and allows for payment
of the clinical pharmacy services
that support the safe use of these
SHPA also expects that everyone,
including government, will learn from
this experience and in future when
negotiations occur around funding
medicines and/or pharmacy services that
government consults more broadly and is
open to innovative solutions that would
avoid poor policy decisions and further
'unintended consequences' to patient
care in an already complex health system.
efficient pricing of
all medicines and
ensuring that tax
payers' money is not
International drug safety
conference for Brisbane
Delegates from across the world will
descend on Brisbane in October for the
4th International Global Drug Safety
Conference and Exposition.
It is being hosted by the PSA
The conference, with the theme
Revitalising Drug Safety -- The Decade of
the Patient, will be held at the Brisbane
Convention & Exhibition Centre from
14--16 October with international and
Australian speakers presenting on a
range of topics focussing on the rapidly
changing environment of drug safety.
The conference will culminate with Global
Drug Safety Day on October 16 when
international attention will be focussed
on the issues of drug safety.
Queensland Branch President,
Dr Lisa Nissen, said the conference would
bring together government leaders,
drug regulatory agencies, drug safety
specialists, healthcare professionals,
pharmaceutical industry, healthcare
technology providers, health insurance
providers, patient safety advocates,
and consumer groups from across
'This is the premier, one-of-kind drug
safety conference and exposition and this
is the first time it has been held outside of
its traditional base of Hong Kong. In this
ever-changing world, drug safety is one of
the most challenging public health issues
that we are facing in our time.
'This conference and exposition
recognises and acts upon the fact that it
is everyone's responsibility to take action
to address the serious threat to global
public health posed by the pressing
issues relating to unsafe medicines and
the unsafe use of medicines.
"Expert speakers will pinpoint exactly the
areas that need to be addressed in drug
safety and also highlight emerging trends
that we must be aware of.
'In addition, presented papers will enable
delegates to be brought up to date with all
the latest research while also providing an
opportunity for broad contribution to the
conference proceedings by industry, the
profession and stakeholders. This is certainly
not a conference to be missed.'
'We will have some very special events to
mark Global Drug Safety Day and these will
complement activities taking place across
the globe," Dr Nissen said.
'The Queensland Branch of PSA is honoured
and excited to be hosting an international
conference of this magnitude and
importance. That we were chosen to host
this event is a very significant recognition
of the high regard in which the work we are
undertaking in Australia surrounding drug
safety is held'.
People who take warfarin have been
reminded to take the medicine safely.
In particular, they should remember that
changes in food and drink intake can affect
how warfarin works -- especially vitamin
K-rich foods like leafy green vegetables,
NPS MedicineWise clinical adviser
Dr Andrew Boyden said that warfarin has
been around for 60 years and is a lifesaving
medicine for people at risk of blood clots
that can cause strokes.
'But if you take warfarin, it's important to
understand how to keep your INR stable and
reduce your risk of bleeding, which is one of
the main side effects.'
Warfarin can interact with many prescription
and non-prescription medicines, including
some herbal and natural medicines.
Foods that are rich in vitamin K can affect
how well warfarin works.
Some examples of foods high in vitamin K
are broccoli (cooked), brussel sprouts, raw
cabbage, gourmet lettuce and spinach.
Dr Boyden also warned that other factors
including smoking, drinking alcohol
(more than one or two standard drinks a day)
and illness can all affect how warfarin works.
Links Archive Australian Pharmacist December 2012 February 2013 Navigation Previous Page Next Page